Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
about
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort studyThe effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.The exposure assessment in current time study: implementation, feasibility, and acceptability of real-time data collection in a community cohort of illicit drug users.Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnershipsRisk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsMortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesA multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York CityPrevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious DiseasTiming of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.Impact of age on retention in care and viral suppressionClinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.Geographic Variations in Retention in Care among HIV-Infected Adults in the United States.Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortExploring How Substance Use Impedes Engagement along the HIV Care Continuum: A Qualitative StudyTime trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.Time to initiation of antiretroviral therapy among patients who Are ART eligible in Rwanda: improvement over timeToward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.Antiretroviral therapy for the prevention of HIV transmission: what will it take?Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy.Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.A Minority of Patients Newly Diagnosed with AIDS Are Started on Antiretroviral Therapy at the Time of Diagnosis in a Large Public Hospital in the Southeastern United States.Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC.Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU.Association of injection drug use with incidence of HIV-associated non-AIDS-related morbidity by age, 1995-2014.HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts.Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals.
P2860
Q28535233-8D05B0CB-BA71-48B8-9427-49B9558F032DQ28538221-2A7F24A8-0842-4097-8C4B-121B2290F11EQ30831694-A91DC308-F6E3-47BD-874F-F4BBAEDB83F9Q31110269-AAE0D905-232F-44E9-A54F-1A2D733F860FQ33440320-0C3D677A-637D-4648-98F4-924CA2590894Q33777533-15EDD673-E0D4-43C8-86C4-432A960B9501Q33831463-057EE3B6-D5A8-4617-829B-F2069CEB0339Q33897770-F52FAB78-9409-44AC-9FBB-560DE8700BE7Q33907350-1C6DE134-FADB-42C5-A20F-037D00368EC7Q34155253-529328F0-2F90-47F4-805A-E0962CBFF4ECQ34398159-168821DB-AE9A-46C1-8BF3-A33CEF4C590FQ34407741-4C11686A-E723-4BFF-B1BE-61B9E1A7EA09Q34606589-623F4DC7-8C7D-4689-885B-5276787AB639Q35033474-D122FD6C-53F1-459D-A0BF-F14A23DC34AEQ35102343-90C265B7-C8EE-4158-89FD-19E8A8D6D8AFQ35589224-4EC1C80F-C4CD-4DD5-B59B-6A39129F4226Q35890672-02628DB9-1BF8-4F73-AB82-3E86BD9493C0Q36167178-7650CC24-4270-4A3C-8C28-50A754081E62Q36171488-AB180130-9861-4FBB-8446-CB495CB80DE0Q36777836-7D5B376E-710E-4204-8493-3AC83E54B4C3Q37047999-B9FB24C8-7500-4E34-A859-D87F7D94A8F6Q37227942-C6D50EC7-A129-4D58-B589-F03EDF499388Q37272301-F081D734-0ED5-4251-A7D6-A701945B64A9Q37357482-E4F9B289-EDE0-4CDD-B890-B28CC7A7FB53Q37610668-81B66A71-59E5-4F05-8FF7-D5D0943CD561Q37635041-E76F5B03-CA51-44C5-94C6-F7093EDEE298Q37693598-27A2E397-A02B-4368-9950-DE386D33E340Q38405184-9426C61B-4BCE-4A47-BF05-0B34714CDD8BQ38960928-1989F2D0-7146-42E8-AD47-E836674FF5ABQ39375427-53609012-4F8A-4C88-B1CF-B63ECDF21F69Q39621488-3FCC4269-2EAC-49A9-B41E-6E9AC96A8430Q39685874-9C7868E7-EAF2-41AA-A78B-79B1227DC752Q40138163-E266CB4E-0A14-4341-8EB0-2A05888AE412Q40341533-6CBAF937-2F07-4DE2-AE89-EA7DBB950E08Q40496704-CAF86248-67A4-4AFD-B420-40087AEB177FQ40695692-A0C96783-2025-4014-BB53-1B51D0A72FDEQ40750446-8A9ACFE8-C234-4BD0-9241-39AA6849B17FQ40754593-7E6D0AD6-EC2B-48CE-8426-D511CE7C2A1EQ40860723-C47C787B-BA4A-41E5-9EA1-FE1B6AAE1670Q47568945-D7782A32-04AC-4837-B4A4-27A5071C6F7D
P2860
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Trends and disparities in anti ...... s in North America, 2001-2009.
@en
type
label
Trends and disparities in anti ...... s in North America, 2001-2009.
@en
prefLabel
Trends and disparities in anti ...... s in North America, 2001-2009.
@en
P2093
P2860
P50
P356
P1476
Trends and disparities in anti ...... s in North America, 2001-2009.
@en
P2093
Ann C Collier
David B Hanna
Gregory D Kirk
Hasina Samji
Heidi M Crane
James H Willig
Jeffrey N Martin
Jennifer E Thorne
Kate Buchacz
P2860
P304
P356
10.1093/CID/CIT003
P407
P577
2013-01-11T00:00:00Z